Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China · Delayed Price · Currency is CNY 27.39
+0.38 (1.41%)
At close: Jan 19, 2026
Jiangsu CoWin Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Operating Revenue | 167.16 | 125.87 | 171.34 | 521.6 | 338.46 | 233.21 | Upgrade |
Other Revenue | 0 | 0 | - | - | - | - | Upgrade |
| 167.17 | 125.88 | 171.34 | 521.6 | 338.46 | 233.21 | Upgrade | |
Revenue Growth (YoY) | 41.46% | -26.53% | -67.15% | 54.11% | 45.13% | 215.41% | Upgrade |
Cost of Revenue | 97.05 | 62.78 | 67.55 | 160.69 | 95.02 | 53.35 | Upgrade |
Gross Profit | 70.11 | 63.09 | 103.79 | 360.91 | 243.44 | 179.86 | Upgrade |
Selling, General & Admin | 135.97 | 130.55 | 132.93 | 99.81 | 71.43 | 38.19 | Upgrade |
Research & Development | 86.09 | 99.23 | 88.26 | 74.02 | 38.58 | 23.76 | Upgrade |
Other Operating Expenses | 4.46 | 2.28 | 1.15 | 1.21 | 1.04 | 0.71 | Upgrade |
Operating Expenses | 238.37 | 253.73 | 243.14 | 184.55 | 112.51 | 63.42 | Upgrade |
Operating Income | -168.26 | -190.64 | -139.35 | 176.36 | 130.93 | 116.44 | Upgrade |
Interest Expense | -1.09 | -1.39 | -1.7 | -1.93 | -1.92 | -0.12 | Upgrade |
Interest & Investment Income | 15.26 | 20.71 | 24.43 | 9.13 | 7.53 | 2.08 | Upgrade |
Currency Exchange Gain (Loss) | 0.43 | 0.43 | 0.52 | 6.08 | -1.09 | -1.2 | Upgrade |
Other Non Operating Income (Expenses) | -0.03 | -0.07 | -0.06 | -0.12 | -0.3 | -0.08 | Upgrade |
EBT Excluding Unusual Items | -153.7 | -170.97 | -116.16 | 189.52 | 135.16 | 117.12 | Upgrade |
Impairment of Goodwill | - | - | -4.27 | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | 6.15 | 3.6 | 13.41 | 1.59 | 0.42 | 1.47 | Upgrade |
Gain (Loss) on Sale of Assets | 0 | -0.21 | 1.24 | -0.51 | 1.26 | - | Upgrade |
Asset Writedown | -2.12 | -3.04 | - | -0.06 | - | -0.03 | Upgrade |
Other Unusual Items | 8.03 | 5.91 | 12.8 | 4.86 | 7.69 | 7.89 | Upgrade |
Pretax Income | -141.64 | -164.7 | -92.98 | 195.4 | 144.53 | 126.44 | Upgrade |
Income Tax Expense | 1.92 | -3.33 | -9.24 | 24.82 | 18.68 | 18.28 | Upgrade |
Earnings From Continuing Operations | -143.56 | -161.38 | -83.74 | 170.57 | 125.85 | 108.16 | Upgrade |
Minority Interest in Earnings | 5.84 | 4.17 | -0.67 | -11.31 | - | - | Upgrade |
Net Income | -137.72 | -157.21 | -84.41 | 159.26 | 125.85 | 108.16 | Upgrade |
Net Income to Common | -137.72 | -157.21 | -84.41 | 159.26 | 125.85 | 108.16 | Upgrade |
Net Income Growth | - | - | - | 26.55% | 16.36% | 1105.55% | Upgrade |
Shares Outstanding (Basic) | 111 | 111 | 113 | 92 | 84 | 70 | Upgrade |
Shares Outstanding (Diluted) | 111 | 111 | 113 | 93 | 84 | 70 | Upgrade |
Shares Change (YoY) | -9.06% | -0.93% | 21.20% | 10.07% | 20.59% | 29.55% | Upgrade |
EPS (Basic) | -1.24 | -1.41 | -0.75 | 1.72 | 1.50 | 1.55 | Upgrade |
EPS (Diluted) | -1.24 | -1.41 | -0.75 | 1.72 | 1.49 | 1.54 | Upgrade |
EPS Growth | - | - | - | 14.97% | -3.24% | 827.95% | Upgrade |
Free Cash Flow | -128.54 | -161.67 | -170.94 | 6.99 | 20.11 | 95.44 | Upgrade |
Free Cash Flow Per Share | -1.16 | -1.45 | -1.52 | 0.07 | 0.24 | 1.36 | Upgrade |
Dividend Per Share | - | - | - | 0.433 | - | - | Upgrade |
Gross Margin | 41.94% | 50.12% | 60.58% | 69.19% | 71.92% | 77.12% | Upgrade |
Operating Margin | -100.66% | -151.45% | -81.33% | 33.81% | 38.69% | 49.93% | Upgrade |
Profit Margin | -82.38% | -124.89% | -49.26% | 30.53% | 37.18% | 46.38% | Upgrade |
Free Cash Flow Margin | -76.89% | -128.44% | -99.77% | 1.34% | 5.94% | 40.92% | Upgrade |
EBITDA | -136.18 | -162.23 | -115.84 | 189.71 | 138.85 | 121.03 | Upgrade |
EBITDA Margin | -81.46% | -128.88% | -67.61% | 36.37% | 41.02% | 51.90% | Upgrade |
D&A For EBITDA | 32.08 | 28.41 | 23.51 | 13.35 | 7.91 | 4.6 | Upgrade |
EBIT | -168.26 | -190.64 | -139.35 | 176.36 | 130.93 | 116.44 | Upgrade |
EBIT Margin | -100.66% | -151.45% | -81.33% | 33.81% | 38.69% | 49.93% | Upgrade |
Effective Tax Rate | - | - | - | 12.71% | 12.93% | 14.46% | Upgrade |
Revenue as Reported | 167.17 | 125.88 | 171.34 | 521.6 | 338.46 | - | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.